Evidence map›Paper›PMID 31803089›Full record

ArticleFrontiers in psychology2019

A Randomized Controlled Trial of Concentrated ERP, Self-Help and Waiting List for Obsessive- Compulsive Disorder: The Bergen 4-Day Treatment.

Gunvor Launes, Kristen Hagen, Tor Sunde, Lars-Göran Öst, Ingrid Klovning, Inger-Lill Laukvik, Joseph A Himle, Stian Solem, Sigurd W Hystad, Bjarne Hansen and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in psychology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02886780 (Concentrated Exposure Treatment), which is not on this map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02886780 naunknown statusnot on this map

Concentrated Exposure Treatment (cET) for Obsessive Compulsive Disorder (OCD). A Randomized Controlled Trial (RCT)

TypeinterventionalSponsorHaukeland University HospitalRan2016 to 2023Enrolled48ConditionsObsessive Compulsive Disorder (OCD)ArmsConcentrated exposure treatment (cET), Self-help
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Epigenetic markers of response to psychotherapy in obsessive-compulsive disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gunvor LaunesSørlandet Sykehus, Kristiansand, Norway.
Kristen HagenDepartment of Psychiatry, Molde Hospital, Molde, Norway.
Tor SundeSørlandet Sykehus, Kristiansand, Norway.
Lars-Göran ÖstBergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway.
Ingrid KlovningSørlandet Sykehus, Kristiansand, Norway.
Inger-Lill LaukvikSørlandet Sykehus, Kristiansand, Norway.
Joseph A HimleDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, United States.
Stian SolemBergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway.
Sigurd W HystadDepartment of Psychosocial Science, University of Bergen, Bergen, Norway.
Bjarne HansenDepartment of Clinical Psychology, University of Bergen, Bergen, Norway.
Gerd KvaleDepartment of Clinical Psychology, University of Bergen, Bergen, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Bergen 4-day treatment (B4DT) is a concentrated exposure-based treatment for patients with Obsessive-Compulsive Disorder (OCD) delivered during four consecutive days. The B4DT has in a number of effectiveness studies demonstrated promising results as approximately 90% of patients gain reliable clinical change post-treatment and nearly 70% are recovered on a long-term basis.

methodsThe current study is the first randomized controlled trial evaluating the effects of the B4DT. Forty-eight patients diagnosed with OCD were randomized to B4DT, self-help (SH), or waiting list (WL) with 16 patients in each condition. All participants randomized to the B4DT underwent the treatment without any attrition.

resultsThe B4DT yielded significantly better effects than control conditions on measures of OCD, depression, and generalized anxiety. The response rate (≥35% reduction of the individual patient's pre-treatment Y-BOCS score) was 93.8% in B4DT, 12.5% in SH and 0% in WL, while remission rate (response criterion is fulfilled and the post-treatment Y-BOCS score is ≤12 points) was 62.5%, 6.3%, and 0%, respectively. Furthermore, patients who had received the B4DT, showed improved work- and social functioning. None of the patients treated with B4DT showed signs of deterioration. In comparison, one patient in the SH condition was in remission, and one showed significant clinical improvement, whereas the remaining showed no change.

conclusionThe results indicate that the B4DT is an effective treatment for patients suffering from OCD. CLINICAL

trial registrationwww.ClinicalTrials.gov, identifier NCT02886780.

Indexed as

B4DTERPgroup therapyobsessive-compulsive disorderOCDRCT

Identifiers

PMID31803089
PMCPMC6873786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.